1. Home
  2. SAGE vs ASA Comparison

SAGE vs ASA Comparison

Compare SAGE & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • ASA
  • Stock Information
  • Founded
  • SAGE 2010
  • ASA 1958
  • Country
  • SAGE United States
  • ASA United States
  • Employees
  • SAGE N/A
  • ASA N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • ASA Precious Metals
  • Sector
  • SAGE Health Care
  • ASA Industrials
  • Exchange
  • SAGE Nasdaq
  • ASA Nasdaq
  • Market Cap
  • SAGE 571.7M
  • ASA 622.9M
  • IPO Year
  • SAGE 2014
  • ASA N/A
  • Fundamental
  • Price
  • SAGE $9.08
  • ASA $32.06
  • Analyst Decision
  • SAGE Hold
  • ASA
  • Analyst Count
  • SAGE 18
  • ASA 0
  • Target Price
  • SAGE $10.06
  • ASA N/A
  • AVG Volume (30 Days)
  • SAGE 2.8M
  • ASA 56.9K
  • Earning Date
  • SAGE 07-30-2025
  • ASA 07-15-2025
  • Dividend Yield
  • SAGE N/A
  • ASA 0.13%
  • EPS Growth
  • SAGE N/A
  • ASA N/A
  • EPS
  • SAGE N/A
  • ASA 11.67
  • Revenue
  • SAGE $47,404,000.00
  • ASA $3,557,386.00
  • Revenue This Year
  • SAGE $102.21
  • ASA N/A
  • Revenue Next Year
  • SAGE $43.01
  • ASA N/A
  • P/E Ratio
  • SAGE N/A
  • ASA $2.78
  • Revenue Growth
  • SAGE N/A
  • ASA 45.39
  • 52 Week Low
  • SAGE $4.62
  • ASA $17.42
  • 52 Week High
  • SAGE $13.47
  • ASA $35.00
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 71.54
  • ASA 50.12
  • Support Level
  • SAGE $9.04
  • ASA $30.35
  • Resistance Level
  • SAGE $9.30
  • ASA $32.83
  • Average True Range (ATR)
  • SAGE 0.15
  • ASA 0.93
  • MACD
  • SAGE 0.05
  • ASA -0.25
  • Stochastic Oscillator
  • SAGE 91.35
  • ASA 40.14

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: